| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $510K | +234.3% |
| Cost of Revenue | $763 | -99.7% |
| Gross Profit | $509K | +440.1% |
| R&D Expense | $179K | -83.1% |
| SG&A Expense | $2.3M | -57.9% |
| Operating Income | -$4.7M | +42.7% |
| Interest Expense | $1.3M | -47.3% |
| Pre-tax Income | -$5.4M | +49.6% |
| Income Tax | -$111K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248K | +312.9% |
| Short-term Investments | $65K | -18.4% |
| Accounts Receivable | $2K | +0.0% |
| Current Assets | $2.2M | +31.6% |
| Total Assets | $7.5M | -48.0% |
| Current Liabilities | $6.6M | +10.5% |
| Total Liabilities | $6.8M | +7.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +57.3% |
| Capital Expenditures | $21K | +0.0% |
| Investing Cash Flow | -$360K | +0.0% |
| Financing Cash Flow | $2.0M | -49.5% |
| Free Cash Flow | -$1.8M | +57.0% |
| -143.2% |
| Net Income | -$4.9M | +53.4% |
| EPS (Basic) | -$0.42 | +82.7% |
| EPS (Diluted) | -$0.42 | +82.7% |
| Stockholders' Equity |
| $1.2M |
| -85.4% |